000 01358 a2200397 4500
005 20250513164105.0
264 0 _c19990507
008 199905s 0 0 eng d
022 _a0264-410X
024 7 _a10.1016/s0264-410x(98)00157-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aArulanandam, B P
245 0 0 _aModulation of mucosal and systemic immunity by intranasal interleukin 12 delivery.
_h[electronic resource]
260 _bVaccine
_cJan 1999
300 _a252-60 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdjuvants, Immunologic
_xtherapeutic use
650 0 4 _aAdministration, Intranasal
650 0 4 _aAnimals
650 0 4 _aAntibody Formation
650 0 4 _aFeces
650 0 4 _aFemale
650 0 4 _aImmunity, Cellular
_ximmunology
650 0 4 _aImmunization
650 0 4 _aInterleukin-12
_xtherapeutic use
650 0 4 _aLung
_ximmunology
650 0 4 _aMice
650 0 4 _aMice, Inbred BALB C
650 0 4 _aNasal Mucosa
_ximmunology
650 0 4 _aReverse Transcriptase Polymerase Chain Reaction
650 0 4 _aSpleen
_ximmunology
650 0 4 _aTh1 Cells
_ximmunology
700 1 _aMetzger, D W
773 0 _tVaccine
_gvol. 17
_gno. 3
_gp. 252-60
856 4 0 _uhttps://doi.org/10.1016/s0264-410x(98)00157-1
_zAvailable from publisher's website
999 _c9948574
_d9948574